Absorption, metabolism, distribution and excretion of (−)-epicatechin: A review of recent findings

Molecular Aspects of Medicine

Volumn 61, Issue , 2018, Pages 18-30

  Borges, Gina ^a   Ottaviani, Javier I ^b   van der Hooft, Justin J J ^c   Schroeter, Hagen ^b   Crozier, Alan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MARS INC   (United States)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

( ) Epicatechin; Absorption; Disposition; Excretion; Flavan 3 ols; Metabolism

Indexed keywords

3 (3' HYDROXYPHENYL)HYDRACRYLIC ACID; 3' HYDROXYHIPPURIC ACID; 3' O METHYL EPICATECHIN 5 SULFATE; 5 (HYDROXYPHENYL) GAMMA HYDROXYVALERIC ACID; 5 (HYDROXYPHENYL) GAMMA VALEROLACTONE; DRUG METABOLITE; EPICATECHIN; EPICATECHIN 3' O GLUCURONIDE; EPICATECHIN 3' SULFATE; HIPPURIC ACID; UNCLASSIFIED DRUG; CATECHIN;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; EX VIVO STUDY; FECES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAXIMUM CONCENTRATION; NONHUMAN; PLASMA; REVIEW; SMALL INTESTINE; SPECIES DIFFERENCE; SPECTROSCOPY; STEREOISOMERISM; URINARY EXCRETION; URINE; ABSORPTION; ANIMAL; BIOAVAILABILITY; BLOOD; CHEMISTRY; METABOLISM; NORMAL HUMAN; TISSUE DISTRIBUTION;

ABSORPTION, PHYSIOLOGICAL; ANIMALS; BIOLOGICAL AVAILABILITY; CATECHIN; HEALTHY VOLUNTEERS; HUMANS; STEREOISOMERISM; TISSUE DISTRIBUTION;

EID: 85033371810     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2017.11.002     Document Type: Review

References (59)

1. Actis-Goretta, L., Lévèques, A., Giuffrida, F., Romanov-Michailidis, F., Viton, D., Barron, D., Duenas-Paton, M., Gonzalez-Manzano, S., Santos-Buelga, C., Williamson, G., Dionisi, F., Elucidation of (−)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic. Biol. Med. 53 (2012), 787–795, 10.1016/j.freeradbiomed.2012.05.023.
2. Actis-Goretta, L., Lévèques, A., Rein, M., Teml, A., Schäfer, C., Hofmann, U., Li, H., Schwab, M., Eichelbaum, M., Williamson, G., Intestinal absorption, metabolism and excretion of (–)-epicatechin in healthy humans assessed by using an intestinal perfusion technique. Am. J. Clin. Nutr. 98 (2013), 924–933, 10.3945/ajcn.113.065789.
3. Baba, S., Osakabe, N., Yasuda, A., Natsume, M., Takizawa, T., Takizawa, T., Nakamura, T., Terao, J., Bioavailability of (–)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Rad. Res. 33 (2000), 635–641.
4. Borges, G., Lean, M.E.J., Roberts, S.A., Crozier, A., Bioavailability of dietary (poly)phenols: a study with ileostomists to discriminate between absorption in the small and large intestine. Food Funct. 4 (2013), 754–762, 10.1039/c3fo60024.
5. 14 C](–)-epicatechin metabolome in rats. Free Rad. Biol. Med. 99 (2016), 128–138, 10.1016/j.freeradbiomed.2016.08.00.
6. Brickman, A.M., Khan, U.A., Provenzano, F.A., Yeung, L.K., Suzuki, W., Schroeter, H., Wall, M., Sloan, R.P., Small, S.A., Enhancing dentate gyrus function with dietary flavonols improves cognition in old adults. Nat. Neurosci. 17 (2014), 1798–17803, 10.1038/nn.3850.
7. Brindani, N., Mena, P., Benzie, I., Choi, S.W., Brighenti, F., Zanardi, F., Curti, C., Del Rio, D., Synthetic and analytical strategies for the quantification of phenyl-γ-valerolactone conjugated metabolites in human urine. Mol. Nutr. Food Res., 2017, 10.1002/mnfr.201700077.
8. Cooper, K.A., Campos-Gimnez, E., Jiménez Alvarez, D., Nagy, K., Donovan, J.L., Williamson, G., Rapid reversed phase ultra-performance liquid chromatography analysis of the major coca polyphenols and inter-relationships of their concentrations in chocolate. J. Agric. Food Chem. 55 (2007), 2841–2847.
9. Cordero-Herrera, I., Martin, M.A., Goya, L., Ramos, S., Cocoa flavonoids protect hepatic cells against high glucose-induced oxidative strees: relevance of MAPKs. Mol. Nutr. Food Res. 59 (2015), 597–609, 10.1002/mnfr.201400492.
10. Crozier, A., Absorption, metabolism and excretion of (–)-epicatechin in humans: an evaluation of recent findings. Am. J. Clin. Nutr. 98 (2013), 861–862, 10.3945/ajcn.113.072009.
11. Crozier, A., Clifford, M.N., Del Rio, D., Bioavailability of dietary monomeric and polymeric flavan-3-ols. Spencer, J.P.E., Crozier, A., (eds.) Flavonoids and Related Compounds. Bioavailability and Function of Flavonoids, 2012, CRC Press, Boca Raton, 45–78.
12. Crozier, A., Del Rio, D., Clifford, M.N., Bioavailability of dietary flavonoids and phenolic compounds. Mol. Asp. Med. 31 (2010), 446–467, 10.1016/j.mam.2010.09.007.
13. Crozier, A., Jaganath, I.B., Mark, S., Saltmarsh, M., Clifford, M.N., Secondary metabolites as dietary components in plant-based foods and beverages. Crozier, A., Clifford, M.N., Ashihara, H., (eds.) Plant Secondary Metabolites: Occurrence, Structure and Role in the Human Diet, 2006, Blackwell Publishing, Oxford, 208–302.
14. Curti, C., Brindani, N., Battistini, L., Sartori, A., Pelosi, G., Mena, P., Brighenti, F., Zanardi, F., Del Rio, D., Catalytic, enantioselective vinylogous mukaiyama aldol reaction of furan-based dienoxy silanes: a chemodivergent approach to γ–valerolactone flavan-3-ol metabolites and δ–lactone analoges. Adv. Synth. Catal. 357 (2015), 4082–4092, 10.1002/adsc.201500705.
15. 13 C-tracer study. Am. J. Clin. Nutr. 97 (2013), 995–1003, 10.3945/ajcn.112.049247.
16. de Ferrars, R.M., Czank, C., Zhang, Q., Botting, N.P., Kroon, P.A., Cassidy, A., Kay, C.D., The pharmacokinetics of anthocyanins and their metabolites in humans. Br. J. Pharmacol. 171 (2014), 3268–3282, 10.1111/bph.12676.
17. Del Rio, D., Rodriguez-Mateos, A.M., Spencer, J.P.E., Tognolini, M., Borges, G., Crozier, A., Dietary (poly)phenolics in human health and disease: structures, bioavailability, evidence of protective effects and potential mechanisms. Antioxid. Redox Signal. 18 (2013), 1818–1892, 10.1083/ars.2012.4581.
18. Faria, A., Pestana, D., Teixeira, D., Couraud, P.O., Romero, J., Weksler, B., de Freitas, V., Mateus, N., Calhau, C., Insights into the putative catechin and epicatechin transport across the blood-brain barrier. Food Funct. 2 (2011), 39–44, 10.1039/c0fo00100g.
19. FDA, Bioavailability and Bioequivalence Studies of Orally Administered Drug Products-general Considerations. 2011.
20. Gotti, R., Furlanetto, S., Pinzauti, S., Cavrini, V., Analysis of catechins in Theobroma cacao beans by cyclodextrin-modified micellar electrokinetic chromatography. J. Chromatogr. A 1112 (2006), 345–352.
21. Gu, L., Kelm, M.A., Hammerstone, J.F., Beecher, G., Holden, J., Haytowitz, D., Gebhardt, S., Prior, R.L., Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J. Nutr. 134 (2004), 613–617.
22. Heiss, C., Keen, C.L., Kelm, M., Flavanols and cardiovascular disease prevention. Eur. Heart J. 31 (2010), 2583–2592, 10.1093/eurheartj/ehq332.
23. Kurlbaum, M., Mulek, M., Hogger, P., Facilitated uptake of a bioactive metabolite of marinepine pine bak extract (pycnogenol) into human erythrocytes. PLoS One, 8, 2013, e63197, 10.1371/journal.pone.0063197.
24. Kutschera, M., Engst, W., Blaut, M., Braune, A., Isolation of a catechin-converting human intestinal bacteria. J. Appl. Microbiol. 111 (2011), 165–175, 10.1111/j.1365-2672.2011.05025.x.
25. Loke, W.M., Hodgson, J.M., Proudfoot, J.M., McKinley, A.J., Puddey, I.B., Croft, K.D., Pure dietary flavonoids quercetin and (–)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am. J. Clin. Nutr. 88 (2008), 1018–1025.
26. Martin, M.A., Fernández-Millán, E., Ramos, S., Bravo, L., Goya, L., Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Mol. Nutr. Food Res. 58 (2014), 447–456, 10.1002/mnfr.201300291.
27. Mull, E.S., van Zandt, M., Golebiowski, A., Beckett, R.P., Sharma, P.K., Schroeter, H., A versatile approach to the regioselective synthesis of diverse (−)-epicatechin-β-D-glucuronides. Tetrahed. Lett. 53 (2012), 1501–1503, 10.1016/j.tetlet.2012.01.054.
28. Mullen, W., Borges, G., Donovan, J.L., Edwards, C.A., Serafini, M., Lean, M.E.J., Crozier, A., Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am. J. Clin. Nutr. 89 (2009), 1784–1791, 10.3945/ajcn.2008.27339.
29. 14 C](–)-epicatechin in humans: implications for the assessment of efficacy safety, and mechanisms of action of polyphenolic bioactives. Sci. Rep., 1(6), 2016, 29034, 10.1038/srep29034.
30. Ottaviani, J.I., Momma, T.Y., Heiss, C., Kwik-Uribe, C., Schroeter, H., Keen, C.L., The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic. Biol. Med. 50 (2011), 237–244, 10.1016/j.freeradbiomed.2010.11.005.
31. Ottaviani, J., Momma, T.Y., Kuhnle, G.K., Keen, C.L., Schroeter, H., Structurally related (−)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic. Biol. Med. 52 (2012), 1403–1412, 10.1016/j.freeradbiomed.2011.12.010.
32. Pereira-Caro, G., Borges, G., Ky, I., Ribas, A., Del Rio, D., Clifford, M.N., Roberts, S.A., Crozier, A., In vitro colonic catabolism of orange juice (poly)phenols. Mol. Nutr. Food Res. 59 (2015), 465–475, 10.1002/mnfr.201400779.
33. Pereira-Caro, G., Borges, G., van der Hooft, J., Clifford, M.N., Del Rio, D., Lean, M.E.J., Roberts, S.A., Kellerhals, M.B., Crozier, A., Orange juice (poly)phenols are highly bioavailable. Am. J. Clin. Nutr. 100 (2014), 1385–1391, 10.3945/ajcn.114.090282.
34. Pereira-Caro, G., Ludwig, I.A., Polyviou, T., Malkova, D., García, A., Moreno-Rojas, J.M., Crozier, A., Identification of plasma and urinary metabolites and catabolites derived from orange juice (poly)phenols: analysis by high-resolution liquid chromatography-high-resolution mass spectrometry. J. Agric. Food. Chem. 64 (2016), 5724–5735, 10.1021/acs.jafc.6b02088.
35. Pereira-Caro, G., Moreno-Rojas, J., Brindin, N., Del Rio, D., Lean, M.E.J., Hara, Y., Crozier, A., Bioavailability of black tea theaflavins: absorption, metabolism and colonic catabolism. J. Agric. Food Chem. 65 (2017), 5365–5374, 10.1021/acs.jafc.7b01707.
36. Pereira-Caro, G., Polyviou, T., Ludwig, I.A., Nastase, A.-M., Ludwig, I.A., Moreno-Rojas, J.M., García, A., Malkova, D., García, A., Crozier, A., Bioavailability of orange juice (poly)phenols: impact of short-term cessation of training by male endurance athletes. Am. J. Clin. Nutr. 106 (2017), 791–800, 10.3945/ajcn.116.149898.
37. Rein, D., Lotito, S., Holt, R.R., Keen, C.L., Schmitz, H.H., Fraga, C.G., Epicatechin in human plasma: In vivo determination and effect of chocolate consumption on plasma oxidation status. J. Nutr. 130 (2000), 2109S–2114S.
38. Richelle, M., Tavazzi, I., Enslen, M., Offord, E.A., Plasma kinetics in man of epicatechin from black chocolate. Eur. J. Clin. Nutr. 53 (1999), 22–26.
39. Rodriguez-Mateos, A., Cifuentes-Gomez, T., Gonzalez-Salvador, I., Ottaviani, J.I., Schroeter, H., Kelm, M., Heiss, C., Spencer, J.P.E., Influence of age on the absorption, metabolism and excretion of cocoa flavanols in healthy subjects. Mol. Nutr. Food Res. 59 (2015), 1504–1512, 10.1002/mnfr.201500091.
40. Rodriguez-Mateos, A.M., Vauzour, D., Kreuger, C.G., Shanmuganayagam, D., Reed, D., Canali, L., Mena, P., Del Rio, D., Crozier, A., Flavonoids and related compounds, bioavailability bioactivity and impact on human health: an update. Arch. Toxicol. 88 (2014), 1803–1853, 10.1007/s00204-014-1330-7.
41. Rothwell, J.A., Perez-Jiménez, J., Neveu, V., Medina-Remón, A., M'hin, N., Garcia-Lobato, P., Monach, C., Knox, C., Eisner, R., Wishart, D., Scalbert, A., Phenol-Explorer 3.0: A major update of the Phenol-Explorer data base to incorporate data on the effects of food processing on polyphenol contents. Database (Oxford), 2013, bap070, 10.1093/database/bap070.
42. Roowi, S., Stalmach, A., Mullen, W., Lean, M.E.J., Edwards, C.A., Crozier, A., Green tea flavan-3-ols: colonic degradation and urinary excretion of catablites by humans. J. Agric. Food Chem. 58 (2010), 1296–1304, 10.1021/jf9032975.
43. Roura, E., Almajano, M.P., Mata-Bilbao, M.L., Andrés-Laceuva, C., Estruch, R., Lamuela-Raventós, R.M., Human urine: epicatechin metabolites and antioxidant activity after cocoa intake. Free Rad. Res. 41 (2007), 943–949.
44. Roura, E., Andrés-Laceuva, C., Estruch, R., Mata-Bilbao, M.L., Izquierdo-Pulido, M., Lamuela-Raventós, R.M., The effects of milk as a food matrix for polyphenols on the excretion profile of cocoa (–)-epicatechin metabolites in healthy human subjects. Br. J. Nutr. 100 (2008), 846–851, 10.1017/S0007114508922534.
45. Roura, E., Andrés-Laceuva, C., Jáuregui, O., Badia, E., Estruch, R., Izquierdo-Pulido, M., Lamuela-Raventós, R.M., Rapid liquid chromatography tandem mass spectrometer assay to quantify plasma (–)-epicatechin metabolites after the ingestion of a standard portion of of cocoa beverage in humans. J. Agric. Food Chem. 53 (2005), 6190–6194.
46. Saha, S., Hollands, W., Needs, P.W., Ostertag, L.M., de Roos, B., Duthie, G.G., Kroon, P.A., Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases:implications for studies concerned with quantifying epicatechin bioavailability. Pharmacol. Res. 65 (2012), 592–602, 10.1016/j.phrs.2012.02.005.
47. Sánchez-Patán, F., Chioua, M., Garrido, I., Cueva, C., Samadi, A., Marco-Contelles, J., Moreno-Arribas, M.V., Bartolomé B., Monaga, M., Synthesis, analytical features, and biological relevance of 5-(3′,4′-dihydroyxphenyl)-γ-valerolactone, a microbial metabolites derived from the catabolism of dietary flavan-3-ols. J. Agric. Food. Chem. 59 (2011), 7083–7091, 10.1021/jf2020182.
48. Sansome, R., Ottaviani, J.I., Rodrigues-Mateos, A., Heinen, Y., Noske, D., Spencer, J.P., Crozier, A., Merx, M.W., Kelm, M., Schroeter, H., Heiss, C., Methylxanthines enhance the effects of cocoa flavanols on cardiovascular function. Am. J. Clin. Nutr. 105 (2017), 352–360, 10.3945/ajcn.116.140046.
49. Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P., Keen, C.L., Hollenberg, N.K., Sies, H., Kwik-Uribe, C., Schmidt, H.H., Kelm, M., (−)-Epicatechin mediates beneficial effects of flavonol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 1024–1029.
50. Sharma, P.K., He, M., Jurayj, J., Gou, D.M., Lombardy, R., Romanczyk, L.J. Jr., Schroeter, H., Enantioselective syntheses of sulfur analogues of flavan-3-ols. Molecules 15 (2010), 5595–5619, 10.3390/molecules15085595.
51. Stalmach, A., Edwards, C.A., Wightman, J., Crozier, A., Gastrointestinal stability and bioavailability of (poly)phenolic compounds following ingestion of Concord grape juice by humans. Mol. Nutr. Food Res. 56 (2012), 497–509, 10.1039/c2fo30151b.
52. Stalmach, A., Mullen, W., Steiling, H., Williamson, G., Crozier, A., Absorption, metabolism, efflux and excretion of green tea flavan-3-ols in humans with an ileostomy. Mol. Nutr. Food Res. 54 (2010), 323–334, 10.1002/mnfr.200900194.
53. Stalmach, A., Troufflard, S., Serafini, M., Crozier, A., Absorption, metabolism and excretion of Choladi green tea flavan-3-ol monomers. Mol. Nutr. Food Res. 53 (2009), S44–S53, 10.1002/mnfr.200800169.
54. Tomás-Barberán, F.A., Cienfuegos-Jovellanos, E., Marín, A., Muguerza, B., Gil-Izquierdo, A., Cera, B., Zafilla, P., Morillas, J., Mulero, J., Ibarra, A., Pasamar, M.A., Ramón, D., Espin, J.C., A new process to develop a cocoa powder with higher flavonoid monomer content and enhanced bioavailabiliy in healthy humans. J. Agric. Food Chem. 55 (2007), 3926–3935, 10.1021/jf070121j.
55. Wang, J., Ferruzi, M.G., Ho, L., Blount, J., Janie, E.M., Gong, B., Pan, Y., Gowda, G.A., Raferty, D., Arrieta-Cruz, I., Sharma, V., Cooper, B., Lobo, J., Simon, J.E., Zhang, C., Cheng, A., Qian, X., Ono, K., Teplow, D.B., Pavlides, C., Dixon, R.A., Pasinetti, G.M., Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J. Neurosci. 32 (2012), 5144–5150, 10.1523/JNEUROSCI.6437-11.2012.
56. Wang, J.F., Schramm, D.D., Holt, R.R., Ensuna, J.L., Fraga, C.G., Schmitz, H.H., Keen, C.L., A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J. Nutr. 130 (2000), 2115S–2119S.
57. Williamson, G., Clifford, M.N., Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Biochem. Pharmacol. 139 (2017), 24–39, 10.1016/j.bcp.2017.03.012.
58. Zhang, M., Jagdmann, E.G. Jr., Van Zandt, M., Beckett, P., Schroeter, H., Enantioselective synthesis of orthogonally protected (2R,3R)-(−)-epicatechin derivatives, key intermediates in the de novo chemical synthesis of (−)-epicatechin glucuronides and sulfates. Tetrahed. Asym 24 (2013), 362–373, 10.1016/j.tetsy.2013.02.012.
59. Zhang, M., Jagdmann, E.G. Jr., Van Zandt, M., Sheeler, R., Beckett, P., Schroeter, H., Chemical synthesis and characterization of epicatechin glucuronindes and sulfates: bioanalytical standards for epictechin metabolite identification. J. Nat. Prod. 76 (2013), 157–169, 10.1021/np300568m.